Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-13776
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
EMD-13776
Single-particle3.4 Å
Deposition: 22/10/2021Map released: 09/03/2022
Last modified: 09/07/2025
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: Trimer of the SARS_CoV-2 S glycoprotein
Fitted models: 7q1z
Deposition Authors: Sulbaran G, Effantin G
Sample: Trimer of the SARS_CoV-2 S glycoprotein
Fitted models: 7q1z
Deposition Authors: Sulbaran G, Effantin G
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Sulbaran G,
Maisonnasse P ,
Amen A ,
Effantin G ,
Guilligay D,
Dereuddre-Bosquet N,
Burger JA,
Poniman M,
Grobben M ,
Buisson M,
Dergan Dylon S,
Naninck T,
Lemaitre J ,
Gros W,
Gallouet AS,
Marlin R ,
Bouillier C,
Contreras V,
Relouzat F,
Fenel D,
Thepaut M,
Bally I,
Thielens N,
Fieschi F,
Schoehn G,
van der Werf S,
van Gils MJ ,
Sanders RW,
Poignard P ,
Le Grand R,
Weissenhorn W
(2022) Cell Rep Med , 3 , 100528 - 100528
,
Amen A ,
Effantin G ,
Guilligay D,
Dereuddre-Bosquet N,
Burger JA,
Poniman M,
Grobben M ,
Buisson M,
Dergan Dylon S,
Naninck T,
Lemaitre J ,
Gros W,
Gallouet AS,
Marlin R ,
Bouillier C,
Contreras V,
Relouzat F,
Fenel D,
Thepaut M,
Bally I,
Thielens N,
Fieschi F,
Schoehn G,
van der Werf S,
van Gils MJ ,
Sanders RW,
Poignard P ,
Le Grand R,
Weissenhorn W
(2022) Cell Rep Med , 3 , 100528 - 100528
Secondary citations:
- Sulbaran G, Maisonnasse P, Amen A, Effantin G, Guilligay D, Dereuddre-Bosquet N, Burger JA, Poniman M, Grobben M, Buisson M, Dergan Dylon S, Naninck T, Lemaitre J, Gros W, Gallouet AS, Marlin R, Bouillier C, Contreras V, Relouzat F, Fenel D, Thepaut M, Bally I, Thielens N, Fieschi F, Schoehn G, van der Werf S, van Gils MJ, Sanders RW, Poignard P, Le Grand R & Weissenhorn W. (2022) Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection. 3, 100528 - 100528
- Sulbaran G, Effantin G, Schoehn G & Weissenhorn W. (2022) Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Grant Support:
- European Union (EU): 681032, H2020 EHVA (France)
- Agence Nationale de la Recherche (ANR): RA-Covid-19 (France)